Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04604067
Title Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Swiss Group for Clinical Cancer Research
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | CHE


No variant requirements are available.